Lilly, SEC Push Toward Deal In FCPA Probe
Drug and medical device maker Eli Lilly & Co. said Friday it was in advanced discussions with the U.S. Securities and Exchange Commission to resolve an investigation into potential violations of...To view the full article, register now.
Already a subscriber? Click here to view full article